Showing 1 - 10 of 179,140
neglected diseases. A number of alternative innovation incentives have therefore been proposed. This paper highlights some of …
Persistent link: https://www.econbiz.de/10014132514
far behind the innovative manufacturing found in other industries. This lack of innovation in drug manufacturing stands in … stark contrast to the innovation present in drug discovery. Drug discovery is the focus of a calibrated innovation policy … dollars and in human lives. This article addresses the previously underappreciated role of manufacturing in innovation studies …
Persistent link: https://www.econbiz.de/10014038452
We examine the role of spillover learning in shaping the value of exploratory versus incremental R&D. Using data from drug development, we show that novel drug candidates generate more knowledge spillovers than incremental ones. Despite being less likely to reach regulatory approval, they are...
Persistent link: https://www.econbiz.de/10014287391
The debate on whether COVID-19 vaccine patents are slowing down the pace of vaccination and the recovery from the crisis has brought the optimal design of pharmaceutical patent policy to the fore. In this paper we evaluate patent policy in the US pharmaceutical industry. We estimate the effect...
Persistent link: https://www.econbiz.de/10012802183
Persistent link: https://www.econbiz.de/10013170079
We provide a theoretical framework to contribute to the current debate regarding the tendency of pharmaceutical companies to direct their R&D toward marketing products that are "follow-on" drugs of already existing drugs, rather than toward the development of breakthrough drugs. We construct a...
Persistent link: https://www.econbiz.de/10011406575
This paper analyses the causal impact of Intellectual Property Rights (IPR) on pharmaceutical innovation in a panel of …. Domestic innovation is measured as citation-weighted domestic patents filed at the European Patent Office (EPO): to account for … to patent at the EPO. Results show that, in the short-run, IPR stimulate innovation. The effect for developing countries …
Persistent link: https://www.econbiz.de/10011509446
Persistent link: https://www.econbiz.de/10010494939
different configurations of the patent system upon innovation and competition. The model is able to replicate the main stylized … adverse effects in terms of innovation outcomes, as well as of market competition and consumer welfare. Such general …
Persistent link: https://www.econbiz.de/10012654995
innovation are necessarily at odds with each other. Although intuitively appealing, the argument that drug regulation negatively … than decreasing the expected returns to innovation, this aspect of regulation contributes to the value of new drugs and may … actually encourage innovation. This point has largely been absent from most cost-benefit analyses of drug regulation, yet …
Persistent link: https://www.econbiz.de/10012754003